logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11845931 B1

PDFFull Text
Date of Patent:
Dec. 19, 2023

Filed:

Mar. 17, 2020

Crispr/cas screening platform to identify genetic modifiers of tau seeding or aggregation

Applicant:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Marine Prissette, Brooklyn, NY (US);

Matthew Koss, Pleasantville, NY (US);

Wen Fury, New York, NY (US);

Brian Zambrowicz, Sleepy Hollow, NY (US);

Assignee:

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Attorneys:

Yongjin Choi

Alston & Bird LLP

Primary Examiner:

Suzanne M Noakes

Assistant Examiner:

Jae W Lee

Int. Cl.
CPC ...
C12N 15/10 (2006.01); C12N 5/00 (2006.01); C12N 5/071 (2010.01); C12N 9/22 (2006.01); C12N 15/113 (2010.01); G01N 21/64 (2006.01); G16B 25/00 (2019.01); A61K 48/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1082 (2013.01); C12N 5/0018 (2013.01); C12N 5/0686 (2013.01); C12N 9/22 (2013.01); C12N 15/1086 (2013.01); C12N 15/1089 (2013.01); C12N 15/113 (2013.01); G01N 21/6428 (2013.01); G01N 33/6896 (2013.01); G16B 25/00 (2019.02); A61K 48/00 (2013.01); C12N 2310/20 (2017.05); C12N 2320/12 (2013.01); C12N 2502/99 (2013.01); C12N 2800/80 (2013.01); G01N 2021/6441 (2013.01); G01N 2800/7047 (2013.01);
Abstract

Cas-protein-ready tau biosensor cells, CRISPR/Cas synergistic activation mediator (SAM)-ready tau biosensor cells, and methods of making and using such cells to screen for genetic modifiers of tau seeding or aggregation are provided. Reagents and methods for sensitizing such cells to tau seeding activity or tau aggregation or for causing tau aggregation are also provided.

Find Patent Forward Citations

Prissette, Marine. (2023). Crispr/cas screening platform to identify genetic modifiers of tau seeding or aggregation (U.S. Patent No. 11845931). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11845931

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…